Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
Common Stock [Member] |
Preferred Stock [Member]
Series D Preferred Stock [Member]
|
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Non-Controlling Interest in Consolidated Subsidiary [Member] |
Total |
| Beginning balance, value at Dec. 31, 2024 |
$ 8,191
|
$ 320,572
|
$ 610,630
|
$ (25,364)
|
$ 1,880
|
$ 915,909
|
| Balance, shares at Dec. 31, 2024 |
81,909
|
|
|
|
|
|
| Common Stock Issued with the DRIP |
$ 16
|
(0)
|
2,596
|
(0)
|
(0)
|
2,612
|
| Common Stock Issued with the DRIP, shares |
152
|
|
|
|
|
|
| Common Stock Issued through Restricted Stock Awards |
$ 22
|
(0)
|
(22)
|
(0)
|
(0)
|
(0)
|
| Common Stock Issued through Restricted Stock Awards, shares |
224
|
|
|
|
|
|
| Common Stock Issued through Stock Options |
$ 2
|
(0)
|
352
|
(0)
|
(0)
|
354
|
| Common Stock Issued through Stock Options, shares |
25
|
|
|
|
|
|
| Preferred Stock Issued in connection with At-The-Market Offerings, net |
$ (0)
|
1,232
|
(250)
|
(0)
|
(0)
|
982
|
| Distributions |
0
|
0
|
(18,000)
|
(4,858)
|
0
|
(22,858)
|
| Stock Compensation Expense |
(0)
|
(0)
|
3,149
|
(0)
|
(0)
|
3,149
|
| Net Income (Loss) |
(0)
|
(0)
|
(0)
|
4,858
|
(48)
|
4,810
|
| Common Stock Issued in connection with At-The-Market Offerings, net |
$ 52
|
(0)
|
9,185
|
(0)
|
(0)
|
9,237
|
| Common Stock Issued in connection with At-The-Market Offerings, net, shares |
515
|
|
|
|
|
|
| Ending balance, value at Mar. 31, 2025 |
$ 8,283
|
321,804
|
607,640
|
(25,364)
|
1,832
|
914,195
|
| Balance, shares at Mar. 31, 2025 |
82,825
|
|
|
|
|
|
| Beginning balance, value at Dec. 31, 2024 |
$ 8,191
|
320,572
|
610,630
|
(25,364)
|
1,880
|
915,909
|
| Balance, shares at Dec. 31, 2024 |
81,909
|
|
|
|
|
|
| Net Income (Loss) |
|
|
|
|
|
21,700
|
| Ending balance, value at Sep. 30, 2025 |
$ 8,520
|
321,885
|
619,651
|
(25,364)
|
1,721
|
926,413
|
| Balance, shares at Sep. 30, 2025 |
85,197
|
|
|
|
|
|
| Beginning balance, value at Mar. 31, 2025 |
$ 8,283
|
321,804
|
607,640
|
(25,364)
|
1,832
|
914,195
|
| Balance, shares at Mar. 31, 2025 |
82,825
|
|
|
|
|
|
| Common Stock Issued with the DRIP |
$ 13
|
|
2,192
|
(0)
|
(0)
|
2,205
|
| Common Stock Issued with the DRIP, shares |
136
|
|
|
|
|
|
| Common Stock Issued through Restricted Stock Awards |
$ 1
|
|
(1)
|
(0)
|
(0)
|
(0)
|
| Common Stock Issued through Restricted Stock Awards, shares |
9
|
|
|
|
|
|
| Common Stock Issued through Stock Options |
$ 1
|
|
136
|
(0)
|
(0)
|
137
|
| Common Stock Issued through Stock Options, shares |
10
|
|
|
|
|
|
| Distributions |
$ 0
|
|
(16,402)
|
(7,661)
|
0
|
(24,063)
|
| Stock Compensation Expense |
(0)
|
|
3,351
|
(0)
|
(0)
|
3,351
|
| Net Income (Loss) |
(0)
|
|
(0)
|
7,661
|
(56)
|
7,605
|
| Common Stock Issued in connection with At-The-Market Offerings, net |
$ 176
|
|
30,152
|
(0)
|
(0)
|
30,328
|
| Common Stock Issued in connection with At-The-Market Offerings, net, shares |
1,761
|
|
|
|
|
|
| Ending balance, value at Jun. 30, 2025 |
$ 8,474
|
321,804
|
627,068
|
(25,364)
|
1,776
|
933,758
|
| Balance, shares at Jun. 30, 2025 |
84,741
|
|
|
|
|
|
| Common Stock Issued with the DRIP |
$ 15
|
(0)
|
2,255
|
(0)
|
(0)
|
2,270
|
| Common Stock Issued with the DRIP, shares |
151
|
|
|
|
|
|
| Common Stock Issued through Restricted Stock Awards |
$ 1
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
| Common Stock Issued through Restricted Stock Awards, shares |
11
|
|
|
|
|
|
| Common Stock Issued through Stock Options |
$ 1
|
(0)
|
43
|
(0)
|
(0)
|
44
|
| Common Stock Issued through Stock Options, shares |
4
|
|
|
|
|
|
| Preferred Stock Issued in connection with At-The-Market Offerings, net |
$ (0)
|
81
|
(22)
|
(0)
|
(0)
|
59
|
| Distributions |
0
|
0
|
(14,907)
|
(9,340)
|
0
|
(24,247)
|
| Stock Compensation Expense |
(0)
|
(0)
|
612
|
(0)
|
(0)
|
612
|
| Net Income (Loss) |
(0)
|
(0)
|
(0)
|
9,340
|
(55)
|
9,285
|
| Common Stock Issued in connection with At-The-Market Offerings, net |
$ 29
|
(0)
|
4,603
|
(0)
|
(0)
|
4,632
|
| Common Stock Issued in connection with At-The-Market Offerings, net, shares |
290
|
|
|
|
|
|
| Ending balance, value at Sep. 30, 2025 |
$ 8,520
|
321,885
|
619,651
|
(25,364)
|
1,721
|
926,413
|
| Balance, shares at Sep. 30, 2025 |
85,197
|
|
|
|
|
|
| Beginning balance, value at Dec. 31, 2025 |
$ 8,485
|
322,899
|
599,520
|
(25,364)
|
1,656
|
907,196
|
| Balance, shares at Dec. 31, 2025 |
84,850
|
|
|
|
|
|
| Common Stock Issued with the DRIP |
$ 16
|
(0)
|
2,351
|
(0)
|
(0)
|
2,367
|
| Common Stock Issued with the DRIP, shares |
155
|
|
|
|
|
|
| Common Stock Issued through Restricted Stock Awards |
$ 12
|
(0)
|
(12)
|
(0)
|
(0)
|
(0)
|
| Common Stock Issued through Restricted Stock Awards, shares |
122
|
|
|
|
|
|
| Common Stock Issued through Stock Options |
$ 1
|
(0)
|
96
|
(0)
|
(0)
|
97
|
| Common Stock Issued through Stock Options, shares |
10
|
|
|
|
|
|
| Preferred Stock Issued in connection with At-The-Market Offerings, net |
$ (0)
|
1,653
|
(189)
|
(0)
|
(0)
|
1,464
|
| Distributions |
0
|
0
|
(16,549)
|
(7,753)
|
0
|
(24,302)
|
| Stock Compensation Expense |
(0)
|
(0)
|
1,523
|
(0)
|
(0)
|
1,523
|
| Net Income (Loss) |
(0)
|
(0)
|
(0)
|
7,753
|
(64)
|
7,689
|
| Ending balance, value at Mar. 31, 2026 |
$ 8,514
|
324,552
|
586,740
|
(25,364)
|
1,592
|
896,034
|
| Balance, shares at Mar. 31, 2026 |
85,137
|
|
|
|
|
|
| Beginning balance, value at Dec. 31, 2025 |
$ 8,485
|
322,899
|
599,520
|
(25,364)
|
1,656
|
907,196
|
| Balance, shares at Dec. 31, 2025 |
84,850
|
|
|
|
|
|
| Net Income (Loss) |
|
|
|
|
|
20,325
|
| Ending balance, value at Sep. 30, 2026 |
$ 8,560
|
339,502
|
556,502
|
(25,364)
|
1,444
|
880,644
|
| Balance, shares at Sep. 30, 2026 |
85,602
|
|
|
|
|
|
| Beginning balance, value at Mar. 31, 2026 |
$ 8,514
|
324,552
|
586,740
|
(25,364)
|
1,592
|
896,034
|
| Balance, shares at Mar. 31, 2026 |
85,137
|
|
|
|
|
|
| Common Stock Issued with the DRIP |
$ 16
|
(0)
|
2,198
|
(0)
|
(0)
|
2,214
|
| Common Stock Issued with the DRIP, shares |
159
|
|
|
|
|
|
| Common Stock Issued through Restricted Stock Awards |
$ 1
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
| Common Stock Issued through Restricted Stock Awards, shares |
11
|
|
|
|
|
|
| Preferred Stock Issued in connection with At-The-Market Offerings, net |
$ (0)
|
8,834
|
(1,650)
|
(0)
|
(0)
|
7,184
|
| Distributions |
0
|
0
|
(14,750)
|
(9,599)
|
0
|
(24,349)
|
| Stock Compensation Expense |
(0)
|
(0)
|
1,273
|
(0)
|
(0)
|
1,273
|
| Net Income (Loss) |
(0)
|
(0)
|
(0)
|
9,599
|
(67)
|
9,532
|
| Ending balance, value at Jun. 30, 2026 |
$ 8,531
|
333,386
|
573,810
|
(25,364)
|
1,525
|
891,888
|
| Balance, shares at Jun. 30, 2026 |
85,307
|
|
|
|
|
|
| Common Stock Issued with the DRIP |
$ 16
|
(0)
|
2,386
|
(0)
|
(0)
|
2,402
|
| Common Stock Issued with the DRIP, shares |
160
|
|
|
|
|
|
| Common Stock Issued through Restricted Stock Awards |
$ 1
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
| Common Stock Issued through Restricted Stock Awards, shares |
11
|
|
|
|
|
|
| Common Stock Issued through Stock Options |
$ 12
|
(0)
|
1,457
|
(0)
|
(0)
|
1,469
|
| Common Stock Issued through Stock Options, shares |
124
|
|
|
|
|
|
| Preferred Stock Issued in connection with At-The-Market Offerings, net |
$ (0)
|
6,116
|
(964)
|
(0)
|
(0)
|
5,152
|
| Distributions |
0
|
0
|
(21,371)
|
(3,185)
|
0
|
(24,556)
|
| Stock Compensation Expense |
(0)
|
(0)
|
1,185
|
(0)
|
(0)
|
1,185
|
| Net Income (Loss) |
(0)
|
(0)
|
(0)
|
3,185
|
(81)
|
3,104
|
| Ending balance, value at Sep. 30, 2026 |
$ 8,560
|
$ 339,502
|
$ 556,502
|
$ (25,364)
|
$ 1,444
|
$ 880,644
|
| Balance, shares at Sep. 30, 2026 |
85,602
|
|
|
|
|
|